Millennium: Caris Life Sciences: $168 Million Raised For Precision Medicine Platform

Caris Life Sciences - a next-generation AI TechBio company and precision medicine pioneer - announced that the company has closed a growth capital funding round of $168 million. With this round of funding, Caris has raised $1.86 billion in capital since 2018. The post Caris Life Sciences: $168 Million Raised For Precision Medicine Platform appeared first on Pulse 2.0.